Open AccessSurvival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients
Author(s) -
Mahsa Taskindoust,
Samantha M. Thomas,
Sarah Sammons,
Oluwadamilola M. Fayanju,
Gayle DiLalla,
E. Shelley Hwang,
Jennifer K. Plichta
Publication year - 2021
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-021-10227-3
Subject(s) - medicine , metastatic breast cancer , hazard ratio , surgical oncology , oncology , breast cancer , proportional hazards model , cancer , confidence interval , hormone receptor , gynecology
Although metastatic breast cancer (MBC) remains incurable, advances in therapies have improved survival. Using a contemporary dataset of de novo MBC patients, we explore how overall (OS) and cancer-specific survival (CSS) changed over time.